Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$3.38
-0.7%
$3.66
$2.68
$41.33
$11.34M2.2110,805 shs52,291 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.00%+2.58%-8.29%+11.39%-90.15%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
1.3213 of 5 stars
3.13.00.00.00.00.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
2.25
Hold$7.00107.41% Upside

Current Analyst Ratings Breakdown

Latest BNGO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2025
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$10.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$30.78M0.37N/AN/A$18.12 per share0.19
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$112.02M-$138.92N/AN/A-294.05%-125.75%-71.96%8/6/2025 (Estimated)

Latest BNGO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$3.49-$1.15+$2.34-$1.15$6.25 million$6.46 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.07
1.70
1.34

Institutional Ownership

CompanyInstitutional Ownership
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
11.35%

Insider Ownership

CompanyInsider Ownership
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
3003.36 million3.33 millionOptionable

Recent News About These Companies

Bionano Genomics Inc News (BNGO) - Investing.com
Bionano Genomics Q1 Earnings Preview
Bionano Genomics announces publication on OGM
Bionano Genomics initiated with a Buy at H.C. Wainwright

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bionano Genomics stock logo

Bionano Genomics NASDAQ:BNGO

$3.38 -0.03 (-0.74%)
Closing price 07/3/2025 03:55 PM Eastern
Extended Trading
$3.38 +0.00 (+0.15%)
As of 07/3/2025 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.